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The aim of this study was to characterize the Escherichia coli K88-specific receptors in mucus from the small
intestines of 35-day-old piglets with the isogenic strains E. coli K-12(pMKO05) (K88+) and E. coli
K-12(pMK002) (K88-). These strains differed only in that the latter one cannot produce intact K88 fimbriae
because of a deletion in the gene coding for the major fimbrial subunit. Adhesion was studied by incubating
3H-labeled bacteria with crude mucus, pronase-treated whole mucus, mucus fractionated by gel filtration,
delipidated mucus, or extracted lipids immobilized in microtiter wells. In addition, E. coli strains were tested
for adhesion to glycolipids extracted from mucus by overlaying glycolipid chromatograms with I251-labeled
bacteria. The recently reported finding that K88 fimbriae bind to glycoproteins in mucus from the piglet small
intestine was confirmed in two ways. Pronase treatment of immobilized mucus reduced adhesion by 82%, and
adhesion to delipidated mucus was 14 times greater for the K88+ than for the K88- strain. E. coli K88+
adhered to several of the fractions collected after gel filtration of crude mucus, including the void volume (Mr,
>250,000). Receptor activity specific for the K88 fimbriae was demonstrated in the lipids extracted from
mucus, as the neutral lipids contained six times as much receptor activity as the acidic lipid fraction. Specificity
was confirmed by demonstrating that adhesion to the total lipids could be inhibited by pretreatment of the
immobilized lipids with K88 fimbriae. Relative to K-12 (K88-), the K-12 (K88+) bacterial cells bound more
avidly to galactosylceramide when the neutral lipids were separated on thin-layer chromatography plates. No
adhesion to lipids in the acidic fraction separated on thin-layer plates was detected. Relative to adhesion ofK-12
(K88-), adhesion of K-12 (K88+) to commercially available galactosylceramide immobilized in microtiter wells
confirmed the results with the thin-layer plates. It can be concluded that 35-day-old piglet mucus contains both
protein and glycolipid receptors specific for K88 fimbriae, the latter being galactosylceramide.
Preweaned and immediately postweaned piglets are par-
ticularly susceptible to diarrhea induced by colonization of
the small intestine by enterotoxigenic Escherichia coli
strains which express K88 fimbriae (26, 27). Antigenic vari-
ants referred to as K88ab, -ac, and -ad fimbriae have been
identified (8, 22). These fimbriae mediate adhesion of the E.
coli K88 strains to the epithelial mucosa lining the small
intestine (2) and thereby contribute to their virulence (10).
Furthermore, piglets which are phenotypically resistant to
E. coli K88-induced diarrhea lack K88-specific receptor in
the epithelial cell brush borders (25). Initially, studies di-
rected towards elucidating the receptor for the K88 fimbriae
concentrated on the receptor involved in the hemagglutina-
tion of guinea pig erythrocytes by K88 (28). Gibbons et al. (7)
succeeded in inhibiting hemagglutination with glycoproteins
from colostrum and then destroyed the effect by removal of
the terminal beta-D-galactose residue. This group of workers
then inhibited hemagglutination with intestinal mucus glyco-
proteins but not serum glycoproteins. In addition, by chem-
ical modification of these mucus glycoproteins, it was appar-
ent that unsubstituted beta-D-galactosyl residues were an
essential part of the receptor. Attention was then directed
towards the brush border receptor for K88 fimbriae. Kearns
* Corresponding author.
t Present address: School of Microbiology, University of New
South Wales, P.O. Box 1, Kensington, New South Wales 2033,
Australia.
and Gibbons (13) showed that brush border polar glycolipids
varied for K88-sensitive and -resistant pigs. Because beta-
D-galactose and periodate interfered with receptor activity,
Sellwood (24) suggested that the receptor was either a
glycoprotein or a glycolipid. Putative receptors for K88
fimbriae have been released into organ cultures of small
intestinal explants and subsequently shown to be a 35-kDa
glycoprotein or protein (32).
More recently, it has been established that receptors for
the K88 fimbriae are detectable in the mucus overlying the
epithelial cells of the piglet small intestine (3, 5, 20, 31). The
amount of K88ab receptor in the mucus was shown to be age
related (3, 5, 31), as is susceptibility to E. coli K88-induced
diarrhea, and it was therefore proposed that the presence of
receptors in mucus may play a role in the pathogenesis of
K88-bearing strains (4, 5).
Mucus consists of numerous glycoproteins, small pro-
teins, lipids, and glycolipids (1) and is highly viscous in its
native form because of mucin, which is a large glycoprotein
(Mr, 2,000,000). Metcalfe et al. (20) showed that piglet small
intestinal mucus contained a glycoprotein (Mr, 42,000) with
specific affinity for K88ab fimbriae by adsorbing purified
fimbriae with mucus and then analyzing them by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). Subsequently, it was shown that K88ab and -ac
fimbriae bound to several small glycoproteins in the same
size range by Western blotting (immunoblotting) mucus
proteins separated by SDS-PAGE (31).
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Glycolipids are frequently reported to function as recep-
tors for a range of bacteria (12, 17) including enterotoxigenic
E. coli carrying K99 fimbriae (18, 30). Both Metcalfe et al.
(20) and Willemsen and deGraaf (31) have detected K88-
specific glycoprotein receptors in piglet intestinal mucus;
however, neither group detected glycolipid receptors. Our
preliminary studies of K88 receptors in ileal mucus showed
that components with an Mr of >250,000 contained K88
receptor activity but little protein. The aim of this study,
therefore, was to investigate the receptor activity of both the
lipid- and the protein-containing fractions of piglet ileal
mucus.
MATERIALS AND METHODS
Bacterial cultures and culturing conditions. The isogenic
strains of E. coli K-12(pMK005) (K88+) and E. coli
K-12(pMK002) (K88-) were obtained by electroporation of
the pMK0O5 and pMK002 plasmids into E. coli K-12. These
plasmids were very kindly provided by D. Pickard, Well-
come Foundation, Beckenham, United Kingdom, as de-
scribed previously (14) and supplied in E. coli HB101. The
pMK005 plasmid contained the pBR322 vector and the
6.5-kbp gene cluster encoding the K88 fimbriae. This 6.5-kbp
gene cluster contained two EcoRI sites, and the pMK002
plasmid was constructed by removing the 1.73-kbp EcoRI
fragment, which contains a large percentage of thefaeD gene
encoding the K88 fimbrial subunit. Although this plasmid
contains the faeA, -B, and -C genes encoding the K88
fimbriae, it cannot produce functional K88 fimbriae, as
confirmed with anti-K88ac serum. In addition, the Gyles
strains of E. coli K88+ and K88- refer to E. coli K-12
containing the entire plasmid on which K88 is located and E.
coli K-12 without the plasmid, respectively. All strains were
stored in 30% glycerol at -70°C and then grown in Trypti-
case soy broth at 37C overnight before use in the various
adhesion assays.
For the adhesion assay, E. coli strains were inoculated
(1%) in Trypticase soy broth and incubated for 5 h and then
reinoculated (1%) in Trypticase soy broth containing 1%
[methyl-1,2-3H]thymidine (specific activity, 117 Ci mmol-1;
Amersham). Cultures were incubated statically overnight at
37°C. The cells were harvested by centrifugation (3,000 x g)
for 7 min at 4°C prior to being washed and resuspended in
HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic
acid)-Hanks buffer (pH 7.2) to yield an optical density of 0.5
(600 nm).
For adhesion to thin-layer chromatography (TLC) plates,
E. coli strains were grown without shaking for 18 h at 37°C in
Trypticase soy broth without added glucose. Broth cultures
were centrifuged at 4°C and 10,000 x g for 20 min, and the
pellets were washed three times in 0.01 M sodium phosphate
(pH 7.2) containing 0.15 M sodium chloride. Bacteria were
radioiodinated as described previously (16). Briefly, approx-
imately 108 cells were transferred to a tube (10 by 75 mm)
coated previously with 100 p,g of Iodogen and reacted with
0.5 mCi of Nal'I at 4°C. The iodination was terminated after
5 min by removal of the cells from the reaction tube,
centrifugation, and three washes in 0.05 M Tris-HCl (pH 7.8)
containing 0.15 M sodium chloride-1% bovine serum albu-
min (TBS-BSA). The labeled bacteria were resuspended to 2
x 106 cpm ml-1 in TBS-BSA.
Mucus collection and fractionation. Mucus was collected
from the ileal region of the small intestines of 35-day-old
piglets by scraping with a rubber spatula and using HEPES-
Hanks buffer. The collected material was centrifuged twice
at 27,000 x g for 20 min to remove bacterial and epithelial
cells prior to being stored in small aliquots at -85°C. Some
of the supernatant was immediately freeze-dried and used
for lipid extraction studies. Mucus was collected from three
piglets and tested separately.
Epithelial cells were also collected from the ileal region of
the three piglets and stored frozen as described previously
(5). These epithelial cells were used to ensure that the three
piglets were of the K88-susceptible phenotype (25). This was
determined by studying the interaction between K88-bearing
E. coli cells and ileal epithelial cells by direct microscopy, as
described by Wilson and Hohmann (33). Several bacteria
bound to the brush border membranes, and very few, if any,
bound to the remainder of the epithelial cells.
Lipids were extracted from the freeze-dried mucus with
chloroform-methanol (2:1) (16) and separated into neutral
and acidic lipids by high-performance liquid chromatography
(HPLC) on silica latrobeads and by anion-exchange chro-
matography on DEAE-cellulose, respectively, as described
previously (15). Lipid fractions were dried under nitrogen
and stored until use. Crude mucus was also fractionated by
gel filtration, using an XK 26/40 column packed with Sepha-
dex 200 SF (Pharmacia), and eluted with HEPES-Hanks at a
flow rate of 1.1 ml cm-2 h-1 and with HEPES-Hanks as the
mobile phase. The crude eluate was monitored by measuring
the A2so. The various fractions were immobilized in the
microtiter wells and tested for receptor activity.
Adhesion to surface-immobilized mucus and components.
Adhesion of E. coli to immobilized mucus was largely
performed as described by Laux et al. (19). Briefly, the
mucus was diluted in HEPES-Hanks buffer (pH 7.2) to yield
0.5 mg of protein ml-1 and immobilized on polystyrene
tissue culture plates (Nunc; Delta) overnight at 4°C. Immo-
bilized BSA was used as a control. The wells were rinsed
twice with 0.5 ml of HEPES-Hanks buffer prior to the
addition of 3H-labeled E. coli. After incubation at 37°C for 1
h, the wells were rinsed twice with 0.5 ml of buffer, and then
0.5 ml of 5% SDS was added to release the irreversibly
bound bacteria by incubating at 60°C for 1 h. The radioac-
tivity of the SDS sample was enumerated with Aquassure
scintillation fluid and a liquid scintillation spectrophotometer
(LS600LL; Beckman).
Characterization of classes of K88 receptors. To determine
whether there were proteinaceous and/or lipid-containing
receptors for K88 fimbriae in the mucus, the following
experiments were carried out.
(i) Crude mucus was diluted to 1 mg of protein ml-1 and
treated with pronase (0.5-mg ml-1 final concentration; Cal-
biochem) for 1 h at 37°C. Controls included BSA (1 mg ml-1)
treated in the same way as well as mucus incubated at 37°C
without pronase addition. After the treatment, samples were
immobilized and the adhesion was carried out as described
above, except that the wells containing the bacteria were
incubated on ice to avoid further activity of the pronase. In
addition, the residual mucus components after extraction of
the lipids were solubilized in HEPES-Hanks buffer and
immobilized in microtiter wells. The presence of receptor
was tested with the 3H-labeled E. coli cells as described
before.
(ii) The total, acidic, and neutral lipids extracted from the
mucus were diluted in methanol to yield 500 ,ug ml-' and
then immobilized on polystyrene tissue culture (Nunc;
Delta) plates at room temperature. After the methanol had
evaporated, BSA (1 mg ml-1) was added to the wells and
immobilized overnight (4°C). Methanol-treated wells simi-
larly covered with BSA were used as controls. Adhesion of
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3H-labeled E. coli cells to treated wells was performed as
described above. In addition, twofold serially diluted lipids
(six steps) were immobilized, and the adhesion of E. coli was
similarly evaluated.
(iii) The specificity of the receptors in the lipids was
evaluated by pretreating the immobilized lipids with crude
K88 fimbrial preparation from E. coli(pMKO05). The fimbrial
extracts were prepared by heat treating the bacterial cells at
60°C for 20 min to release the fimbriae and then centrifuging
twice at about 10,000 x g for 20 min to remove the bacterial
cells. Immobilized mucus containing K88-specific receptors
was pretreated with the K88 fimbrial preparation. Because
the heat treatment used to release the K88 fimbriae from the
cell may also release other components, heat extracts of E.
coli(pMKO02) were used as controls.
Adhesion to TLC plates. Lipids were chromatographed on
aluminum-backed silica gel HPTLC plates developed in
chloroform-methanol-0.25% aqueous KCl (5:4:1). The
plates were coated with polyisobutylmethacrylate (0.1% in
hexane), soaked in TBS-BSA, and incubated for 2 h at room
temperature with 1251I-labeled E. coli cells (2 x 106 cpm ml- 1)
suspended in TBS-BSA. The plates were gently washed to
remove unbound bacteria, dried, and exposed for 24 h to
XAR-5 X-ray film (Eastman Kodak, Rochester, N.Y.). Al-
ternatively, the plates were sprayed with orcinol reagent to
identify glycolipids (16).
Receptor activity of surface-immobilized galactosylceram-
ide. Pure galactosylceramide (galactocerebroside; C 4905,
Sigma Chemical Co.) was diluted in methanol (500 ,ug ml1-)
and then dried in microtiter wells as described above. After
BSA treatment, 3H-labeled E. coli cells were added; after a
10-min incubation, the extent of adhesion was determined as
described above.
RESULTS
Mucus samples from all piglets yielded comparable re-
sults, and so the results of one mucus batch are presented as
typical. Gel filtration of crude mucus revealed that the K88
fimbriae had affinity for the void volume (Mr, >250,000) as
well as several other fractions (Fig. 1).
Evidence of proteinaceous receptor activity in mucus. E.
coli K-12(pMKO05) (K88+) only differs from E. coli
K-12(pMKO02) (K88-) in that the pMKO05 plasmid contains
a functional K88 gene cluster while the latter does not.
Consequently, enhanced adhesive characteristics of the
strain containing plasmid pMKO05 relative to the strain
containing pMKO02 are attributable to the K88 fimbriae. As
illustrated in Fig. 2, E. coli(pMKO05) adhered to mucus
approximately 12 times more than E. coli(pMKO02), whereas
adhesion of the two strains to the control surface of BSA was
equivalent. This adhesion mediated by the K88 fimbriae was
reduced by 82% + 4% (mean + standard deviation) after
pronase treatment (data not shown). Consistently, the adhe-
sion of the E. coli(pMKO05) K88+ strain to immobilized
delipidated mucus was 14 times greater than the adhesion of
the E. coli(pMKO02) K88- strain to the lipid-free mucus
(data not shown).
Evidence of lipid receptor activity. Although the amount of
receptor varied slightly from one mucus preparation to the
next, all three mucus preparations had adhesion profiles
similar to that of total lipids. Neutral and acidic lipids were
extracted from two different mucus preparations from differ-
ent pigs, and the K88+ and K88- strains [E. coli K-12
(pMKO05) and E. coli K-12(pMKO02), respectively] exhib-
ited a consistent profile of adhesion to both preparations. It
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FIG. 1. Typical adhesion pattern of E. coli K-12 (K88-) (a) and
E. coli K-12 (K88') (b) Gyles isogenic mutants to immobilized
fractions collected from gel filtration of crude mucus. TheA280 of the
eluate from the column was monitored (continuous line), and the
degree of adhesion is expressed as the amount of radioactivity
remaining on the surface (open circles).
was found that E. coli K-12(pMKO05) (K88+) adhered sig-
nificantly better to crude mucus and total and neutral lipids
than E. coli K-12(pMKO02) (K88-) (Fig. 2). In addition, the
adhesion of the K88+ strain (pMKO05) to the acidic lipid
fraction was only one-sixth of the adhesion to the neutral
fraction. Nonspecific adhesion of the K88+ strain (pMKO05)
to the control surface (BSA) was very low compared with
the adhesion to mucus and total and neutral lipids (Fig. 2).
Serial dilution of the various lipid fractions showed that the
500-,ug ml-' concentration was appropriate for studies di-
rected to understanding the nature of this lipid receptor (Fig.
3) and that adhesion was measurable with as little as 125 ,ug
of lipid ml-1 for the total lipids. While the extent of adhesion
decreased rapidly with decreasing concentration of total and
60T
50
O40
30
20
10
total neutral acidic BSA Mucus
FIG. 2. Adhesion of isogenic strains E. coli K-12(pMKO05)
(K88+) (open bars) and E. coli K-12(pMKO02) (K88-) (shaded bars)
to piglet ileal mucus and the total, neutral, and acidic lipids
extracted from the mucus after incubation together for 60 min. BSA
was used as the control surface, and adhesion is expressed as the
percentage of the total number of bacteria that remained on the
surface. Results are means ± standard deviations of three individual
experiments, each involving three assays.
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FIG. 3. Adhesion of E. coli(pMKO05) to various concentrations
of total (closed circles), neutral (open squares), and acidic (open
diamonds) lipids. Adhesion is expressed as the amount of radioac-
tivity remaining on the surface. Lipids were diluted stepwise from
an initial concentration of 500 ,ug ml-'.
neutral lipids, K88-mediated adhesion to the acidic lipids
was low with the 500-Rg ml-' concentration and decreased
slowly with decreasing concentration of lipid (Fig. 3).
The specificity of the adhesion of E. coli K-12(pMKO05) to
the total lipids was tested with crude K88 fimbrial prepara-
tions. Immobilized lipids were pretreated with the heat
extracts from E. coli K-12(pMKO05) (K88+) or E. coli
K-12(pMKO02) (K88-) cells prior to the adhesion assay. The
adhesion of E. coli K-12(pMKO02) (K88-) to the total lipids
as well as to the control mucus and BSA was unaffected by
pretreatment of the mucus and mucus fractions with the heat
extracts of pMKO05 and pMKO02 (Fig. 4a). As can be seen in
Fig. 4b, this pretreatment of the mucus with K88-containing
extracts resulted in a 70% reduction in adhesion (relative to
the HEPES-Hanks-treated control) of E. coli K-12
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FIG. 4. Adhesion of E. coli K-12(pMKO02) (K88-) (a) and E. coli
K-12(pMKO05) (K88+) (b) to immobilized crude mucus, total lipids,
and BSA after pretreatment of the immobilized material with heat
extracts (i.e., crude fimbrial preparations) from either the K88+
strain (hatched bars) or the K88- strain (open bars) or with
HEPES-Hanks buffer (stippled bars). Results are expressed as
percentage of the total number of bacterial cells which adhered
(mean + standard deviation of three individual assays) when bacte-
ria were incubated on the immobilized mucus for 30 min.
(pMKO05), while extracts from the strain containing plasmid
pMKO02 (K88-) had little effect on adhesion of K-12
(pMK0O5) to the mucus (Fig. 4b). Similarly, adhesion of
K-12(pMKO05) to total lipids was inhibited by pretreatment
of the lipids with the K88 fimbriae but not by the heat
extracts from the K88- strain (pMKO02). The nonspecific
adhesion of K-12(pMKO05) to the control surface BSA was
not affected by the K88 fimbriae or the pMKO02 heat
extracts.
Identification of the lipid receptor. The specific lipid(s) with
affinity for the K88 fimbriae was identified by overlaying the
radioactively labeled E. coli cells on the various lipid frac-
tions after separation by TLC. The results of these studies
are presented in Fig. 5. The total and neutral lipids contained
many bands, whereas the acidic fraction contained a very
limited number (Fig. 5A). E. coli(pMKO05) K88+ cells
adhered strongly to one band in both the total and neutral
lipids (lanes 2 and 3, respectively, Fig. 5B) and very weakly
to a second band. The band to which the K88+ strain
adhered strongly corresponded in mobility to the authentic
standard. In addition, these K88+ cells adhered to the
standard galactosylceramide as well as to pure galactosyl-
ceramide (lanes 1 and 4, respectively, Fig. 5B). Adhesion of
the K88- (pMK0O2) cells to the galactosylceramide was very
low, as was adhesion of both K88+ and K88- cells to the
bands from the acidic lipid fraction. The K88- cells also
adhered to a band in the same position as the one for which
the K88+ cells had a weak affinity.
The affinity of the E. coli cells for galactosylceramide was
also tested by immobilizing the pure lipid to polystyrene
microtiter wells. As can be seen in Fig. 6, the E.
coli(pMKO05) K88+ cells were three times more adhesive to
the galactosylceramide than the K88- cells, while both of
these E. coli strains adhered equally poorly to the BSA
control.
DISCUSSION
The isogenic strains of E. coli K-12 containing plasmids
pMKO05 and pMKO02 only differed in that the former
contained a functional K88 fimbrial gene cluster and the
latter did not. Any detected difference in receptor activity
between the two could therefore be directly attributable to
the K88 fimbriae. Previously, workers (5, 20, 31) have
utilized the isogenic strains E. coli K-12 (K88+) and E. coli
K-12 (K88-) originally constructed by insertion into K-12 of
the entire wild plasmid on which the K88 genome was
located. The K88- strain therefore did not contain any of the
genes encoded by that plasmid, for example, raffinose utili-
zation. For all subsequent studies, results are presented for
only E. coli K-12(pMKO05) and E. coli K-12(pMKO02).
Pronase treatment of mucus decreased adhesion of the
K88+ (K-12[pMKO05]) strain by 82%. Furthermore, because
adhesion to delipidated mucus of the K88+ (pMKO05) strain
was 14 times greater than that of the K88- [K-12(pMKO02)]
strain, one can suggest that a proteinaceous receptor is
present in the mucus. This is consistent with the findings of
Metcalfe et al. (20) and Willemsem and deGraaf (31), who
reported affinity of purified K88 fimbriae for glycoproteins.
Although both of these studies failed to detect lipid receptors
for K88 in piglet ileal mucus, it appears that our mucus
preparations do contain lipid receptors. Relative to the K88-
[K-12(pMKO02)] strain, the K88+ [K-12(pMKO05)] strain
adheres extremely well to both total lipids and neutral lipids
(Fig. 2), while nonspecific adhesion of this K88+ strain to the
immobilized BSA control was very low. One can therefore
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125I-E. coil K88+ 12SIE. coli K88-
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FIG. 5. Adhesion of '25I-labeled E. coli K-12(pMKO05) (K88+) (B) and E. coli K-12(pMKO02) (K88-) (C) to mucus lipids separated by
TLC. Glycolipids were identified by spraying orcinol reagent on a TLC plate not incubated with bacteria (A). Lanes: 1, 1 ,ug each of the
standards galactosylceramide (CMH), lactosylceramide doublet (CDH), trihexosylceramide (CTH), globoside (GL4), and gangliosides GM3,
GM2, GM1, GD3, GDla, GDlb, and GTlb; 2, total lipids from 0.203 mg (dry weight) of mucus; 3, neutral lipids from 0.583 mg (dry weight)
of mucus; 4, purified galactosylceramide (1 ,ug); 5, acidic lipids from 0.556 mg (dry weight) of mucus.
suggest that the adhesion to lipids is due to specific binding
of the K88 fimbriae to a lipid and, in particular, to a neutral
lipid. Dilution of the total and neutral lipids immobilized in
the microtiter wells resulted in a rapid decrease in adhesive
activity of the K88' (pMKO05) strain, consistent with the
suggestion that mucus contains a lipid receptor (Fig. 3).
Adhesion of the K88+ [K-12(pMKO05)] strain to the acidic
fraction was only one-sixth of the adhesion to the neutral
fraction.
Consistently, adhesion of these K88+ cells to total lipids
was inhibited by the crude K88 fimbrial preparation but not
by the extract from the K88- [K-12(pMKO05)] strain, and
the adhesion to BSA was unaffected by these crude fimbrial
preparations (Fig. 4b). The results from the TLC studies
support the findings presented in Fig. 2 and 4 that mucus
contains a K88-specific neutral lipid receptor. The K88+
(pMKO05) strain did not adhere to the acidic lipid fraction on
the TLC plates, consistent with the data presented in Fig. 2
for adhesion to this fraction upon immobilization in the
microtiter wells.
From the TLC studies, it appears that the lipid receptor is
galactosylceramide (Fig. 5). Although the K88+ (pMKO05)
1.5
0.1
._
< 0.5
0
iLT
galactocerebroside BSA
FIG. 6. Adhesion of E. coli K-12(pMKO02) (K88-) (open bars)
and E. coli K-12(pMKO05) (K88+) (shaded bars) to commercial
galactosylceramide immobilized on microtiter wells. Results are
expressed as percentage of total cells added that adhered (mean ±
standard deviation of three assays).
cells had a weak affinity for a second band on the TLC plates
(Fig. 5), the K88- cells also adhered weakly to a band of the
same size. Consequently, this adhesion is not mediated by
the K88 fimbriae. When commercially available galactosyl-
ceramide was immobilized in the plastic microtiter wells,
adhesion of the K88+ [K-12(pMKO05)] strain was three
times greater than that of the K88- [K-12(pMKO02)] strain
(Fig. 6), consistent with the TLC data. This difference is not
as great as that noted for adhesion to the neutral lipids from
the mucus and could be because the galactosylceramide in
the mucus probably differs in fatty acid composition relative
to the commercial bovine galactosylceramide. The fatty acid
residue present in the amide linkage of ceramides can vary in
chain length, can be saturated or unsaturated, and can exist
as hydroxylated and nonhydroxylated residues (23). Such
chemical differences can influence conformation and thus
reactivity of the glycolipid. Monoclonal antibodies have
been used to discriminate structural differences (21) and to
illustrate the altered reactivity of various ceramides (6, 9, 11,
29). One can therefore hypothesize that the affinity of
ceramide for the K88 fimbriae will vary for ceramides of
different origins.
In summary, piglet ileal mucus contains both protein and
glycolipid receptors for K88. The lipid receptor was detect-
able in both the total and the neutral lipids, and K88 fimbrial
preparations inhibited this adhesion. It is suggested that the
lipid receptor is galactosylceramide.
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